UTRS (Minerva Surgical) Change In Receivables: $-0.72 Mil (TTM As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Minerva Surgical Change In Receivables?

Minerva Surgical UTRS -99.00% Change In Receivables is $-0.72 Mil as of Sep. 2023.

Minerva Surgical's change in receivables for the quarter that ended in Sep. 2023 was $0.30 Mil. It means Minerva Surgical's Accounts Receivable declined by $0.30 Mil from Jun. 2023 to Sep. 2023 .

Minerva Surgical's change in receivables for the fiscal year that ended in Dec. 2022 was $0.05 Mil. It means Minerva Surgical's Accounts Receivable declined by $0.05 Mil from Dec. 2021 to Dec. 2022 .

Minerva Surgical's Accounts Receivable for the quarter that ended in Sep. 2023 was $7.57 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Minerva Surgical's Days Sales Outstanding for the three months ended in Sep. 2023 was 57.72.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Minerva Surgical's liquidation value for the three months ended in Sep. 2023 was $-26.64 Mil.

Minerva Surgical  (OTCPK:UTRS) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Minerva Surgical's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=7.569/11.965*91
=57.72

2. In Ben Graham's calculation of liquidation value, Minerva Surgical's accounts receivable are only considered to be worth 75% of book value:

Minerva Surgical's liquidation value for the quarter that ended in Sep. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=11.125-52.53+0.75 * 7.569+0.5 * 18.183
=-26.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minerva Surgical Change In Receivables Related Terms

Minerva Surgical Change In Receivables Historical Data

* Premium members only.

The historical data trend for Minerva Surgical's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minerva Surgical Change In Receivables Chart

Minerva Surgical Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Change In Receivables
-0.33 -4.43 1.09 0.05

Minerva Surgical Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 -0.45 0.01 -0.57 0.30

Minerva Surgical Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.72 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $-0.72 Mil mean?
Minerva Surgical (UTRS) has a Change In Receivables of $-0.72 Mil as of Sep. 2023. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Minerva Surgical and its competitors.
Is Minerva Surgical's Change In Receivables too high?
Minerva Surgical's current Change In Receivables is $-0.72 Mil.
How does Minerva Surgical's Change In Receivables compare to PAVM and ELUT?
Minerva Surgical's Change In Receivables of $-0.72 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Devices & Instruments company?
A good Change In Receivables depends on the Medical Devices & Instruments industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Minerva Surgical and its competitors. Minerva Surgical's current Change In Receivables is $-0.72 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minerva Surgical stock overvalued right now?
Minerva Surgical (UTRS) has a current Change In Receivables of $-0.72 Mil. The current Change In Receivables is $-0.72 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Minerva Surgical (UTRS), the current Change In Receivables is $-0.72 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minerva Surgical Business Description

Address 4255 Burton Drive, Santa Clara, CA, USA, 95054
Minerva Surgical Inc is a medical device company that develops therapeutic devices that treat abnormal uterine bleeding in a minimally invasive manner. The Company operates and manages its business as one reportable and operating segment, which is the business of research, development, and sale of therapeutic devices for abnormal uterine bleeding treatment.